2016•Zhonghua gan-dan waike zazhiRequires access

Effect of atorvastatin on patients with obstructive hepatolithiasis treated with partial hepatectomy

Weidong Hu, Chaobo Chen, Zhao Wanwen

Open publisher page 0 citations

Abstract

Objective To evaluate the effect of atorvastatin on patients with hepatolithiasis and obstructive jaundice after partial hepatectomy. Methods We retrospectively analyzed the data of 51 patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy from July 2006 to August 2015 at Xishan People's Hospital of Wuxi. Based on whether atorvastatin was used or not, the patients were divided into the treatment group (25 patients) and the control group (26 patients). Liver function tests were determined regularly after operation. The serum liver function on postoperative day 3 (P3d) and postoperative day 5 (P5d), complications (incisional infection, abdominal infection, pleural effusion, peritoneal effusion and bile leakage) and duration of hospital stay in the two groups of patients were compared. Results There was no perioperative death in the two groups. When compared with the control group, liver function data suggested an improvement in the treatment group, as ALT and AST in the treatment group were significantly lower than in the control group on P3d and P5d [ALT(252.6±87.0) U/L vs (385.0±152.9)U/L, (89.9±28.2) U/L vs (116.9±29.3)U/L; AST(130.7±66.9) U/L vs (212.7±80.0) U/L, (47.5±16.1) vs (69.2±12.2) U/L, all P<0.05]. When compared with the control group, the serum cholesterol level was lower on P3d and P5d [TC: (6.7±0.3) mmol/L vs (6.2±0.3) mmol/L; (6.1±0.4) mmol/L vs (7.0±0.4) mmol/L, P<0.05], the serum CRP level was also lower in the treatment group [(56.8±15.7) mg/L vs (98.9±40.3)mg/L, P<0.05]; the duration of hospital stay was (10±1) days in the treatment group, which was significantly different from the control group (12±1) days. Conclusion The use of atorvastatin in patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy improved postoperative liver function and shortened postoperative hospital stay. Key words: Atorvastatin; Obstructive jaundice; Hepatolithiasis; Hepatectomy

About this research paper

What this paper is about

Objective To evaluate the effect of atorvastatin on patients with hepatolithiasis and obstructive jaundice after partial hepatectomy. Methods We retrospectively analyzed the data of 51 patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy from July 2006 to August 2015 at Xishan People's Hospital of Wuxi. Based on whether atorvastatin was used or not, the patients were divided into the treatment group (25 patients) and the control group (26 patients). Liver function tests were determined regularly after operation. The serum liver function on postoperative day 3 (P3d) and postoperative day 5 (P5d), complications (incisional infection, abdominal infection, pleural effusion, peritoneal effusion and bile leakage) and duration of hospital stay in the two groups of patients were compared. Results There was no perioperative death in the two groups. When compared with the control group, liver function data suggested an improvement in the treatment group, as ALT and AST in the treatment group were significantly lower than in the control group on P3d and P5d [ALT(252.6±87.0) U/L vs (385.0±152.9)U/L, (89.9±28.2) U/L vs (116.9±29.3)U/L; AST(130.7±66.9) U/L vs (212.7±80.0) U/L, (47.5±16.1) vs (69.2±12.2) U/L, all P<0.05]. When compared with the control group, the serum cholesterol level was lower on P3d and P5d [TC: (6.7±0.3) mmol/L vs (6.2±0.3) mmol/L; (6.1±0.4) mmol/L vs (7.0±0.4) mmol/L, P<0.05], the serum CRP level was also lower in the treatment group [(56.8±15.7) mg/L vs (98.9±40.3)mg/L, P<0.05]; the duration of hospital stay was (10±1) days in the treatment group, which was significantly different from the control group (12±1) days. Conclusion The use of atorvastatin in patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy improved postoperative liver function and shortened postoperative hospital stay. Key words: Atorvastatin; Obstructive jaundice; Hepatolithiasis; Hepatectomy

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the effect of atorvastatin on patients with hepatolithiasis and obstructive jaundice after partial hepatectomy. Methods We retrospectively analyzed the data of 51 patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy from July 2006 to August 2015 at Xishan People's Hospital of Wuxi. Based on whether atorvastatin was used or not, the patients were divided into the treatment group (25 patients) and the control group (26 patients). Liver function tests were determined regularly after operation. The serum liver function on postoperative day 3 (P3d) and postoperative day 5 (P5d), complications (incisional infection, abdominal infection, pleural effusion, peritoneal effusion and bile leakage) and duration of hospital stay in the two groups of patients were compared. Results There was no perioperative death in the two groups. When compared with the control group, liver function data suggested an improvement in the treatment group, as ALT and AST in the treatment group were significantly lower than in the control group on P3d and P5d [ALT(252.6±87.0) U/L vs (385.0±152.9)U/L, (89.9±28.2) U/L vs (116.9±29.3)U/L; AST(130.7±66.9) U/L vs (212.7±80.0) U/L, (47.5±16.1) vs (69.2±12.2) U/L, all P<0.05]. When compared with the control group, the serum cholesterol level was lower on P3d and P5d [TC: (6.7±0.3) mmol/L vs (6.2±0.3) mmol/L; (6.1±0.4) mmol/L vs (7.0±0.4) mmol/L, P<0.05], the serum CRP level was also lower in the treatment group [(56.8±15.7) mg/L vs (98.9±40.3)mg/L, P<0.05]; the duration of hospital stay was (10±1) days in the treatment group, which was significantly different from the control group (12±1) days. Conclusion The use of atorvastatin in patients with hepatolithiasis and obstructive jaundice who were treated with partial hepatectomy improved postoperative liver function and shortened postoperative hospital stay. Key words: Atorvastatin; Obstructive jaundice; Hepatolithiasis; Hepatectomy

Key concepts: Medicine, Hepatolithiasis, Gastroenterology, Internal medicine, Perioperative, Hepatectomy, Pleural effusion, Liver function

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of atorvastatin on patients with obstructive hepatolithiasis treated with partial hepatectomy — Research Paper | ScholarLens